Editage
Research Solutions English Editing AI Solutions Publication Support Journal Finder Corporate Solutions More

Journal of Hematology and Oncology

eISSN: 1756-8722pISSN: 1756-8722
JournalOpen Access

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Key Metrics

CiteScore
27.5
Eigenfactor
0.01 - 0.05
Impact Factor
>= 25
SJR
Q1Oncology
SNIP
3.41
Time to Publish
time-to-publish View Chart
3  Mo

Journal Specifications

Overview
  • Publisher
    BMC
  • Language
    English
  • Frequency
    Continuous publication
  • Article Processing Charges
    EUR 3690 | USD 4390 | GBP 3090
  • Publication Time
    6
  • Editorial Review Process
    Anonymous peer review
General Details
Publication Details
Editorial Review Detail
Information for authors
View less
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 42%
4-6 53%
7-9 4%
>9 0%

Topics Covered

Cancer
Bone marrow
Proteasome
Immunotherapy
Overall survival
Human cancer
Heparan Sulfate Proteoglycans
Chimeric antigen receptor
Hepatocellular carcinoma
Rituximab
Cell therapy
Objective response
Dual inhibitor
Cell lymphoma
Hematopoietic stem cell transplantation
Flow cytometry
Assay
Colorectal cancer
Lung cancer
Tumor microenvironment

Recently Published Papers

FAQs

Since when has Journal of Hematology and Oncology been publishing? Faqs

The Journal of Hematology and Oncology has been publishing since 2008 till date.

How frequently is the Journal of Hematology and Oncology published? Faqs

Journal of Hematology and Oncology is published Continuous publication.

Who is the publisher of Journal of Hematology and Oncology? Faqs

The publisher of Journal of Hematology and Oncology is BMC.

How can I view the journal metrics of Journal of Hematology and Oncology on editage? Faqs

For the Journal of Hematology and Oncology metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Journal of Hematology and Oncology? Faqs

The eISSN number is 1756-8722 and pISSN number is 1756-8722 for Journal of Hematology and Oncology.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Cancer, Bone marrow, Proteasome, Immunotherapy, Overall survival, Human cancer, Heparan Sulfate Proteoglycans, Chimeric antigen receptor, Hepatocellular carcinoma, Rituximab, Cell therapy, Objective response, Dual inhibitor, Cell lymphoma, Hematopoietic stem cell transplantation, Flow cytometry, Assay, Colorectal cancer, Lung cancer, Tumor microenvironment.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.